Cryoport, Inc. (CYRX) stock
CYRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3022% above fair value
$20.17+0.43 (+2.18%)
Close on Nov 18, 2026Market cap $1.02BP/E –Yield –
Cryoport operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Cryoport's operating income for the twelve months ending Jun 30, 2026 was -$39.62M. For fiscal 2025 it was -$36.81M. The highest annual figure on record is -$5.08M in fiscal 2014.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$36.81M | – |
| FY2024 | Dec 31, 2024 | -$121.67M | – |
| FY2023 | Dec 31, 2023 | -$100.54M | – |
| FY2022 | Dec 31, 2022 | -$31.90M | – |
| FY2021 | Dec 31, 2021 | -$17.83M | – |
| FY2020 | Dec 31, 2020 | -$30.01M | – |
| FY2019 | Dec 31, 2019 | -$17.68M | – |
| FY2018 | Dec 31, 2018 | -$8.64M | – |
| FY2016 | Mar 31, 2016 | -$8.74M | – |
| FY2015 | Mar 31, 2015 | -$5.59M | – |
| FY2014 | Mar 31, 2014 | -$5.08M | – |
| FY2013 | Mar 31, 2013 | -$6.32M | – |
| FY2012 | Mar 31, 2012 | -$7.43M | – |
| FY2011 | Mar 31, 2011 | -$5.60M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | -$10.04M | – |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | -$9.61M | – |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | -$10.03M | – |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | -$9.93M | – |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | -$9.65M | – |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | -$7.19M | – |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | -$12.75M | – |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | -$13.39M | – |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | -$78.03M | – |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | -$17.51M | – |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | -$55.25M | – |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | -$16.91M | – |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | -$18.33M | – |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | -$10.05M | – |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | -$11.04M | – |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | -$7.80M | – |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | -$5.25M | – |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | -$7.82M | – |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | -$8.36M | – |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | -$4.58M | – |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | -$3.75M | – |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | -$1.14M | – |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | -$9.85M | – |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | -$10.73M | – |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | -$5.85M | – |
| Q1 FY2020CQ1 2020 | Mar 31, 2020 | -$3.59M | – |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | -$878.00K | – |
| Q3 FY2019CQ3 2019 | Sep 30, 2019 | -$12.35M | – |
| Q2 FY2019CQ2 2019 | Jun 30, 2019 | -$2.30M | – |
| Q1 FY2019CQ1 2019 | Mar 31, 2019 | -$2.14M | – |
| Q4 FY2018CQ4 2018 | Dec 31, 2018 | -$2.22M | – |
| Q3 FY2018CQ3 2018 | Sep 30, 2018 | -$2.16M | – |
| Q2 FY2018CQ2 2018 | Jun 30, 2018 | -$2.47M | – |
| Q1 FY2018CQ1 2018 | Mar 31, 2018 | -$1.80M | – |
| Q4 FY2016CQ1 2016 | Mar 31, 2016 | $0 | – |
| Q3 FY2016CQ4 2015 | Dec 31, 2015 | -$2.68M | – |
| Q2 FY2016CQ3 2015 | Sep 30, 2015 | -$1.82M | – |
| Q1 FY2016CQ2 2015 | Jun 30, 2015 | -$1.62M | – |
| Q4 FY2015CQ1 2015 | Mar 31, 2015 | -$2.62M | – |
| Q3 FY2015CQ4 2014 | Dec 31, 2014 | -$1.36M | – |
See a number that looks wrong?